Product Review

Product News: 02 2014

Cutis. 2014 February;93(2):111

This month's featured products include the cross-linking polymer film technology Strateris, which will be featured at the 72nd Annual Meeting of the American Academy of Dermatology. GlaxoSmithKline obtains US Food and Drug Administration approval of Mekinist (trametinib) tablets for use in combination with Tafinlar (dabrafenib) capsules for the treatment of patients with unresectable or metastatic melanoma with BRAF V600E or V600K mutations. Niadyne, Inc, launches the Priority Club to reward physicians for using its products. Promius Pharma, LLC partners with AmeriCares to launch the Promius Promise Patient Assistance Program to help patients, who are prescribed Zenatane (isotretinoin) for severe recalcitrant nodular acne, and providers meet acne treatment requirements for isotretinoin therapy.
Read the Full Article

 

Recommended Reading

Minocycline-Induced Hyperpigmentation Involving the Oral Mucosa After Short-term Minocycline Use
MDedge Dermatology
Treating Acne Scars in Patients With Fitzpatrick Skin Types IV to VI Using the 1450-nm Diode Laser
MDedge Dermatology
High-dose isotretinoin restrains acne relapse
MDedge Dermatology
Cosmetic Corner: Dermatologists Weigh in on Face Washes
MDedge Dermatology
Antibiotic Use: Yet Another Threat?
MDedge Dermatology
A primer on pediatric acne
MDedge Dermatology
Product News: 10 2013
MDedge Dermatology
Azelaic acid 15% gel tames women’s acne
MDedge Dermatology
Laser Resurfacing for Treatment of Acne Scarring in Fitzpatrick Skin Types V to VI: Practical Approaches to Maximizing Safety
MDedge Dermatology
Fever, Eosinophilia, and Death: A Case of Minocycline Hypersensitivity
MDedge Dermatology